…and some to hold, avoid or sell

CLS Holdings

The Times

CLS has honed its unglamorous but profitable portfolio of office blocks in suburban locations with good transport links in Britain, Germany and France. Low vacancy rates and rising valuations are commendable. Hold. 273p.

Dixons Carphone

The Times

Apple’s warning that the coronavirus outbreak could hit iPhone production has had a knock-on effect on this retailer, which has been suffering weak mobile phone sales anyway. Avoid. 135p.

Indivior

Investors Chronicle

The pharma group has shifted focus to injectable treatments for opioid addiction after cheap, generic alternatives hit Suboxone Film sales. But a 44% slump in US sales is “alarming”, as are continued legal problems. Sell. 40p.

Metro Bank

Investors Chronicle

The new CEO must produce a credible turnaround plan for the lender. But potential will be hard to square with an overwrought balance sheet, vanishing profitability and regulatory investigation. Sell. 190p.

NMC Health

The Sunday Telegraph

A short-seller has raised doubts over the Gulf-based hospital group’s finances. The founder has quit, and there are concerns over directors’ dealings. Shares are up, but confidence has been shaken. Sell. 855.2p.

Persimmon

The Sunday Times

Despite concerns about building standards, the housebuilder is on track to report a second year of profits topping £1bn. A “flurry of activity” is expected before the end of Help to Buy, and it yields 7.21%. Hold. £32.82.